Tiotropium is the first long-acting anticholinergic drug that has been developed in the early 1990s and approved for the management of stable COPD. [102] The efficacy and safety of tiotropium in all ...

ATS 2012, SAN FRANCISCO – Use of inhaled anticholinergics (IACs) has been associated with an increased risk of potentially dangerous heart arrhythmias among young asthma patients, according to a study ...

Use of inhaled anticholinergics (IACs) has been associated with an increased risk of potentially dangerous heart arrhythmias among young asthma patients, according to a new study. Use of inhaled ...

Among black adults with asthma treated with an inhaled corticosteroid, adding a long-acting beta-agonist did not improve the time to an asthma exacerbation compared with adding the anticholinergic ...

Anticholinergic agents have been available for the treatment of airways obstruction for many decades. For patients with chronic obstructive pulmonary disease (COPD), many practitioners believe that ...

Arnuity™ Ellipta® now available in the US for once-daily treatment of asthma. Incruse® Ellipta® now available in the US for once-daily treatment for COPD. GlaxoSmithKline plc (LSE/NYSE: GSK) today ...

The addition of multiple doses of inhaled ipratropium (an anticholinergic) to beta2-agonists may reduce the rate of hospital admissions in children and adults with moderate-to-severe asthma ...

New research is raising concerns that certain asthma medications – known as inhaled anticholinergics (IACs) – may be associated with an increased risk of potentially dangerous heart arrhythmias, or ...

Dr. Wasserman answers the question: 'Standard Treatment Strategy For Asthma?' — -- Question: What is the standard treatment strategy for asthma? Answer: The standard treatment of asthma is to ...

Customizing Treatment in Severe Refractory Asthma: The Role of Endotyping The addition of a long-acting beta-agonist to an inhaled corticosteroid did not improve the time to an asthma exacerbation in ...

Ipratropium bromide was introduced into the management of obstructive airway diseases in the mid-1970s. Since the introduction of this short-acting rapid-onset bronchodilator in clinical practice, ...

Arnuity™ Ellipta® now available in the US for once-daily treatment of asthma. Incruse® Ellipta® now available in the US for once-daily treatment for COPD. Arnuity ™ Ellipta (fluticasone furoate ...